CN113588614B - 一种营养补充剂对卡博替尼安全用药影响的检测方法 - Google Patents
一种营养补充剂对卡博替尼安全用药影响的检测方法 Download PDFInfo
- Publication number
- CN113588614B CN113588614B CN202110855871.1A CN202110855871A CN113588614B CN 113588614 B CN113588614 B CN 113588614B CN 202110855871 A CN202110855871 A CN 202110855871A CN 113588614 B CN113588614 B CN 113588614B
- Authority
- CN
- China
- Prior art keywords
- cabozantinib
- taking
- nutritional supplement
- liquid
- solution
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
Images
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N21/00—Investigating or analysing materials by the use of optical means, i.e. using sub-millimetre waves, infrared, visible or ultraviolet light
- G01N21/62—Systems in which the material investigated is excited whereby it emits light or causes a change in wavelength of the incident light
- G01N21/63—Systems in which the material investigated is excited whereby it emits light or causes a change in wavelength of the incident light optically excited
- G01N21/64—Fluorescence; Phosphorescence
- G01N21/6402—Atomic fluorescence; Laser induced fluorescence
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N1/00—Sampling; Preparing specimens for investigation
- G01N1/28—Preparing specimens for investigation including physical details of (bio-)chemical methods covered elsewhere, e.g. G01N33/50, C12Q
- G01N1/38—Diluting, dispersing or mixing samples
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N21/00—Investigating or analysing materials by the use of optical means, i.e. using sub-millimetre waves, infrared, visible or ultraviolet light
- G01N21/62—Systems in which the material investigated is excited whereby it emits light or causes a change in wavelength of the incident light
- G01N21/63—Systems in which the material investigated is excited whereby it emits light or causes a change in wavelength of the incident light optically excited
- G01N21/64—Fluorescence; Phosphorescence
- G01N21/6428—Measuring fluorescence of fluorescent products of reactions or of fluorochrome labelled reactive substances, e.g. measuring quenching effects, using measuring "optrodes"
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N21/00—Investigating or analysing materials by the use of optical means, i.e. using sub-millimetre waves, infrared, visible or ultraviolet light
- G01N21/62—Systems in which the material investigated is excited whereby it emits light or causes a change in wavelength of the incident light
- G01N21/63—Systems in which the material investigated is excited whereby it emits light or causes a change in wavelength of the incident light optically excited
- G01N21/64—Fluorescence; Phosphorescence
- G01N21/6428—Measuring fluorescence of fluorescent products of reactions or of fluorochrome labelled reactive substances, e.g. measuring quenching effects, using measuring "optrodes"
- G01N2021/6432—Quenching
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Physics & Mathematics (AREA)
- Chemical & Material Sciences (AREA)
- Immunology (AREA)
- General Health & Medical Sciences (AREA)
- Pathology (AREA)
- General Physics & Mathematics (AREA)
- Life Sciences & Earth Sciences (AREA)
- Analytical Chemistry (AREA)
- Biochemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Optics & Photonics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Investigating, Analyzing Materials By Fluorescence Or Luminescence (AREA)
- Investigating Or Analysing Biological Materials (AREA)
Abstract
Description
Claims (5)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202110855871.1A CN113588614B (zh) | 2021-07-28 | 2021-07-28 | 一种营养补充剂对卡博替尼安全用药影响的检测方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202110855871.1A CN113588614B (zh) | 2021-07-28 | 2021-07-28 | 一种营养补充剂对卡博替尼安全用药影响的检测方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN113588614A CN113588614A (zh) | 2021-11-02 |
CN113588614B true CN113588614B (zh) | 2023-07-14 |
Family
ID=78251165
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202110855871.1A Active CN113588614B (zh) | 2021-07-28 | 2021-07-28 | 一种营养补充剂对卡博替尼安全用药影响的检测方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN113588614B (zh) |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN104819970A (zh) * | 2015-05-20 | 2015-08-05 | 贵州大学 | 一种超分子配合物荧光探针测定水中多菌灵的方法 |
CN107421930A (zh) * | 2017-07-14 | 2017-12-01 | 信阳师范学院 | 一种采用荧光光谱法研究稀土金属La3+与BSA的相互作用的方法 |
CN107941764A (zh) * | 2017-11-16 | 2018-04-20 | 信阳师范学院 | 一种采用荧光光谱法研究茄子提取物与牛血清白蛋白相互作用的方法 |
CN109922790A (zh) * | 2016-09-12 | 2019-06-21 | 珠海贝海生物技术有限公司 | 卡博替尼制剂 |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6468757B2 (en) * | 2000-01-25 | 2002-10-22 | The Research Foundation Of State University Of New York | Method for determining drug-serum protein binding |
-
2021
- 2021-07-28 CN CN202110855871.1A patent/CN113588614B/zh active Active
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN104819970A (zh) * | 2015-05-20 | 2015-08-05 | 贵州大学 | 一种超分子配合物荧光探针测定水中多菌灵的方法 |
CN109922790A (zh) * | 2016-09-12 | 2019-06-21 | 珠海贝海生物技术有限公司 | 卡博替尼制剂 |
CN107421930A (zh) * | 2017-07-14 | 2017-12-01 | 信阳师范学院 | 一种采用荧光光谱法研究稀土金属La3+与BSA的相互作用的方法 |
CN107941764A (zh) * | 2017-11-16 | 2018-04-20 | 信阳师范学院 | 一种采用荧光光谱法研究茄子提取物与牛血清白蛋白相互作用的方法 |
Non-Patent Citations (3)
Title |
---|
曹团武 ; 杨季冬 ; 蔡思彬 ; .卡马西平与牛血清白蛋白的相互作用.华西药学杂志.2008,(第04期),第46-48页. * |
王晓芳等."卡博替尼与血清白蛋白的相互作用研究".《辽宁大学学报 自然科学版》.2021,第第48卷卷(第第2期期),第147-150页. * |
王晓霞 ; 聂智华 ; 李松波 ; 马力通 ; 刘金彦 ; 王正德 ; 闫慧 ; .多光谱法与分子对接法研究盐酸四环素与牛血清白蛋白的相互作用.光谱学与光谱分析.2018,(第08期),第150-158页. * |
Also Published As
Publication number | Publication date |
---|---|
CN113588614A (zh) | 2021-11-02 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Lin et al. | Spectroscopic investigation of interaction between mangiferin and bovine serum albumin | |
Cao et al. | A simple and sensitive method for visual detection of heparin using positively-charged gold nanoparticles as colorimetric probes | |
Hu et al. | Spectroscopic studies on the interaction between methylene blue and bovine serum albumin | |
Brown et al. | The chemistry of the gold drugs used in the treatment of rheumatoid arthritis | |
Zhou et al. | 18β-Glycyrrhetinic acid interaction with bovine serum albumin | |
Mustafa et al. | Glycated human DNA is a preferred antigen for anti-DNA antibodies in diabetic patients | |
Jattinagoudar et al. | Evaluation of the binding interaction between bovine serum albumin and dimethyl fumarate, an anti-inflammatory drug by multispectroscopic methods | |
Mehraban et al. | Binding study of novel anti-diabetic pyrimidine fused heterocycles to β-lactoglobulin as a carrier protein | |
Li et al. | Interaction of oridonin with human serum albumin by isothermal titration calorimetry and spectroscopic techniques | |
Deng et al. | Characterization of the interaction between nitrofurazone and human serum albumin by spectroscopic and molecular modeling methods | |
Holm et al. | Ligand binding induces a sharp decrease in hydrophobicity of folate binding protein assessed by 1-anilinonaphthalene-8-sulphonate which suppresses self-association of the hydrophobic apo-protein | |
Zhou et al. | Characterization of the interaction between furosemide and bovine serum albumin | |
Raza et al. | Biophysical investigation of interactions between sorbic acid and human serum albumin through spectroscopic and computational approaches | |
Voicescu et al. | Spectroscopic study of 3-Hydroxyflavone-protein interaction in lipidic bi-layers immobilized on silver nanoparticles | |
CN104434784B (zh) | 聚肌胞注射液药物组合物和制法 | |
CN113588614B (zh) | 一种营养补充剂对卡博替尼安全用药影响的检测方法 | |
Ramesh et al. | Indirect spectrofluorimetric determination of piroxicam and propranolol hydrochloride in bulk and pharmaceutical preparations | |
Lin et al. | Study on interaction of mangiferin to insulin and glucagon in ternary system | |
Alhazzani et al. | A dual emissive silver-riboflavin complex and nitrogen-doped carbon dot nanoprobe for ratiometric detection of glutathione | |
Shao et al. | Pyrene‐Based Self‐Assembling Peptide for Ratiometric Detection of Heparin | |
Sharma et al. | Simple and rapid RP-HPLC method for simultaneous determination of acyclovir and zidovudine in human plasma | |
CN113655036B (zh) | 一种判断氨基酸是否影响卡博替尼合理用药的方法 | |
Hou et al. | Synchronous fluorescence determination of human serum albumin with methyl blue as a fluorescence probe | |
CN104897627B (zh) | 一种基于分子识别的荧光检测叶酸的方法 | |
CN107436311B (zh) | 一种鉴别胰岛素单体或胰岛素多聚体的方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
CB03 | Change of inventor or designer information | ||
CB03 | Change of inventor or designer information |
Inventor after: Wang Xiaofang Inventor after: Sun Liang Inventor after: Liu Bin Inventor after: Shen Ruchi Inventor after: Shi Jiahao Inventor after: Wang Lei Inventor before: Sun Liang Inventor before: Liu Bin Inventor before: Shen Ruchi Inventor before: Shi Jiahao Inventor before: Wang Xiaofang Inventor before: Wang Lei |
|
GR01 | Patent grant | ||
GR01 | Patent grant |